You are here

generics

Indivior shares dive after Dr Reddy's gets FDA approval for generic

Indivior shares dive after Dr Reddy's gets FDA approval for generic

Reuters

opioid addiction

Flag link:

Allergan: Restasis Lawsuit From Kroger, Walgreens Could Cost Billions

Allergan: Restasis Lawsuit From Kroger, Walgreens Could Cost Billions

NY Shock Exchange

Flag link:

A Look at FDA's FY2018 Generic Drug Performance

A Look at FDA's FY2018 Generic Drug Performance

RAPS.org

Flag link:

Second Patent Cliff Lies Ahead for Pharma With $251 Billion in Sales at Risk by 2024

Second Patent Cliff Lies Ahead for Pharma With $251 Billion in Sales at Risk by 2024

Center for Biosimilars

Flag link:

What to Expect for AstraZeneca in Fiscal 2018

What to Expect for AstraZeneca in Fiscal 2018

Market Realist

Flag link:

CEO: Win or lose on Ampyra patents, Acorda reps are safe with Parkinson's prospect

CEO: Win or lose on Ampyra patents, Acorda reps are safe with Parkinson's prospect

Fierce Pharma

Acorda Therapeutics

Flag link:

FDA: Generics Approved in 2017 Led to $8.8B in Savings

FDA: Generics Approved in 2017 Led to $8.8B in Savings

RAPS.org

Flag link:

EU makes it easier for companies to produce generic medicines for export

EU makes it easier for companies to produce generic medicines for export

Reuters

European Commission

Flag link:

FDA demonizes pharma over generics, but most company reputations can take the blow

FDA demonizes pharma over generics, but most company reputations can take the blow

Fierce Pharma

pharma industry

Flag link:

Tribe taking steps to ‘ramp up’ drug patent business

Tribe taking steps to ‘ramp up’ drug patent business

Drug Delivery Business News

Native Americans

Flag link:

FDA calls out 39 drug companies for allegedly blocking access to generics

FDA calls out 39 drug companies for allegedly blocking access to generics

Stat

Valeant Pharmaceuticals

Flag link:

FDA website to call out branded drugmakers for blocking generics

FDA website to call out branded drugmakers for blocking generics

Biopharma Dive

Flag link:

List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape

List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape

GoinPharma

Shanghai Fosun Pharmaceutical

Apollo Global Management

Flag link:

Perrigo postpones launch of generic to Teva’s ProAir

Perrigo postpones launch of generic to Teva’s ProAir

GoinPharma

Teva Pharmaceutical

Flag link:

FDA Denies Mylan Petition on Advair Generics

FDA Denies Mylan Petition on Advair Generics

RAPS.org

Flag link:

Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die

Glaxo's Advair Is the $100 Billion Asthma Drug That Won't Die

Yahoo/Bloomberg

Flag link:

Appeals Court Struck Down a Price Gouging Law – What About Other Approaches

Appeals Court Struck Down a Price Gouging Law – What About Other Approaches

CP Wire

state legislation

Flag link:

Healthcare on the Hill - A Look at the Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (S.974)

Healthcare on the Hill - A Look at the Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (S.974)

CP WIre

Healthcare on the Hill

CREATES Act of 2017

Flag link:

U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs

U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs

Reuters

Impax Laboratories

Flag link:

Generic-Drug Companies to Face First Charges in U.S. Probe

Generic-Drug Companies to Face First Charges in U.S. Probe

Bloomberg

Teva Pharmaceutical

Flag link:

Pages